The global sclerotherapy market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of venous disease, gastrointestinal bleeding, bronchopleural fistula and cystic diseases. The market is also driven by the rising demand for minimally invasive procedures and growing awareness about the benefits of sclerotherapy over other treatment options.
The detergents segment accounted for the largest share in 2018 due to its wide range of applications in various fields such as medical devices, textile industry and food industry. Osmotic agents are expected to witness fastest growth during the forecast period due to their ability to dissolve blood clots without causing any damage or injury to surrounding tissues or organs. Chemical irritants are expected to witness slowest growth during the forecast period due to their high risk profile associated with side effects like skin irritation and allergic reactions among others.
-The market for sclerotherapy is expected to grow at a CAGR of 3.5% from 2017 to 2025.
Industry Growth Insights published a new data on “Sclerotherapy Market”. The research report is titled “Sclerotherapy Market research by Types (Detergents, Osmotic agents, Chemical irritants), By Applications (Venous disease, Gastrointestinal bleeding, Bronchopleural fistula, Cystic disease), By Players/Companies BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group, Bioniche Pharma Group Ltd, Omega Pharmaceuticals, Angiodynamics, ENDO-FLEX, MTW ENDOSKOPIE, Cook Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sclerotherapy Market Research Report
By Type
Detergents, Osmotic agents, Chemical irritants
By Application
Venous disease, Gastrointestinal bleeding, Bronchopleural fistula, Cystic disease
By Companies
BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group, Bioniche Pharma Group Ltd, Omega Pharmaceuticals, Angiodynamics, ENDO-FLEX, MTW ENDOSKOPIE, Cook Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Sclerotherapy Market Report Segments:
The global Sclerotherapy market is segmented on the basis of:
Types
Detergents, Osmotic agents, Chemical irritants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Venous disease, Gastrointestinal bleeding, Bronchopleural fistula, Cystic disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BTG
- Kreussler
- LGM Pharma
- Troikaa
- Changan Tianyu group
- Bioniche Pharma Group Ltd
- Omega Pharmaceuticals
- Angiodynamics
- ENDO-FLEX
- MTW ENDOSKOPIE
- Cook Medical
Highlights of The Sclerotherapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Detergents
- Osmotic agents
- Chemical irritants
- By Application:
- Venous disease
- Gastrointestinal bleeding
- Bronchopleural fistula
- Cystic disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sclerotherapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sclerotherapy is a medical procedure that uses a needle to inject a solution of salt and ethanol into the skin. The goal of sclerotherapy is to shrink or eliminate lesions (lesions are areas on the skin that are not normal).
Some of the major companies in the sclerotherapy market are BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group, Bioniche Pharma Group Ltd, Omega Pharmaceuticals, Angiodynamics, ENDO-FLEX, MTW ENDOSKOPIE, Cook Medical.
The sclerotherapy market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sclerotherapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sclerotherapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sclerotherapy Market - Supply Chain
4.5. Global Sclerotherapy Market Forecast
4.5.1. Sclerotherapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sclerotherapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sclerotherapy Market Absolute $ Opportunity
5. Global Sclerotherapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sclerotherapy Market Size and Volume Forecast by Type
5.3.1. Detergents
5.3.2. Osmotic agents
5.3.3. Chemical irritants
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sclerotherapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sclerotherapy Market Size and Volume Forecast by Application
6.3.1. Venous disease
6.3.2. Gastrointestinal bleeding
6.3.3. Bronchopleural fistula
6.3.4. Cystic disease
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sclerotherapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sclerotherapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sclerotherapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sclerotherapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sclerotherapy Demand Share Forecast, 2019-2026
9. North America Sclerotherapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sclerotherapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sclerotherapy Market Size and Volume Forecast by Application
9.4.1. Venous disease
9.4.2. Gastrointestinal bleeding
9.4.3. Bronchopleural fistula
9.4.4. Cystic disease
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sclerotherapy Market Size and Volume Forecast by Type
9.7.1. Detergents
9.7.2. Osmotic agents
9.7.3. Chemical irritants
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sclerotherapy Demand Share Forecast, 2019-2026
10. Latin America Sclerotherapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sclerotherapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sclerotherapy Market Size and Volume Forecast by Application
10.4.1. Venous disease
10.4.2. Gastrointestinal bleeding
10.4.3. Bronchopleural fistula
10.4.4. Cystic disease
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sclerotherapy Market Size and Volume Forecast by Type
10.7.1. Detergents
10.7.2. Osmotic agents
10.7.3. Chemical irritants
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sclerotherapy Demand Share Forecast, 2019-2026
11. Europe Sclerotherapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sclerotherapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sclerotherapy Market Size and Volume Forecast by Application
11.4.1. Venous disease
11.4.2. Gastrointestinal bleeding
11.4.3. Bronchopleural fistula
11.4.4. Cystic disease
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sclerotherapy Market Size and Volume Forecast by Type
11.7.1. Detergents
11.7.2. Osmotic agents
11.7.3. Chemical irritants
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectionsby Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sclerotherapy Demand Share, 2019-2026
12. Asia Pacific Sclerotherapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Application
12.4.1. Venous disease
12.4.2. Gastrointestinal bleeding
12.4.3. Bronchopleural fistula
12.4.4. Cystic disease
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sclerotherapy Market Size and Volume Forecast by Type
12.7.1. Detergents
12.7.2. Osmotic agents
12.7.3. Chemical irritants
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sclerotherapy Demand Share, 2019-2026
13. Middle East & Africa Sclerotherapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Application
13.4.1. Venous disease
13.4.2. Gastrointestinal bleeding
13.4.3. Bronchopleural fistula
13.4.4. Cystic disease
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sclerotherapy Market Size and Volume Forecast by Type
13.7.1. Detergents
13.7.2. Osmotic agents
13.7.3. Chemical irritants
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sclerotherapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sclerotherapy Market: Market Share Analysis
14.2. Sclerotherapy Distributors and Customers
14.3. Sclerotherapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BTG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kreussler
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LGM Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Troikaa
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Changan Tianyu group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bioniche Pharma Group Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Omega Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Angiodynamics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ENDO-FLEX
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. MTW ENDOSKOPIE
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cook Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
